Learning Points {#S0001}
===============

Once the diagnosis of acromegaly is made, it is recommended to increase the dose of insulin sensitizers like metformin and reduce the dose of sulfonylureas like glimepiride to preserve the pancreatic beta cell mass to make it possible in future to stop the medications directed towards controlling blood glucose levels completely.[@CIT0001]

Even for patients with long-standing diabetes mellitus in acromegaly, it is possible to stop the anti-diabetic medications within few years after the removal of GH producing tumor.

In patients with very high GH levels at the time of diagnosis (\>40 ng/mL), second pituitary surgery might be required even after a successful surgery to meet the required results.

Dopamine agonists like cabergoline might be required to reduce the IGF-1 levels along with pituitary surgery.

Background {#S0002}
==========

In this patient, the acromegaly was undiagnosed for several years. The patient informed that the changes in the face, suggestive of acromegaly, started around 10 years before she was finally diagnosed of the condition. At the time of diagnosis, the serum GH levels were more than 40 ng/mL. The GH testing was done through chemiluminescence method.

Case Presentation {#S0003}
=================

A 54-year-old woman presented with uncontrolled blood glucose levels with history of diabetes mellitus since 12 years. Her blood glucose levels have been uncontrolled since 5 years with HbA1C at the time of the diagnosis of acromegaly at around 12%. Her facial features like mandibular overgrowth, unusually thick lips (see [Figure 1](#F0001){ref-type="fig"}), forehead protrusion, and other signs like enlarged hands and feet raised the suspicion of acromegaly[@CIT0002],[@CIT0003] in which the pituitary produces an excess of growth hormone. High serum growth hormone levels cause insulin resistance, gluconeogenesis in the liver and lipolysis leading to uncontrolled blood glucose levels.[@CIT0004],[@CIT0005] As the serum growth hormones levels increase so do the blood glucose levels.Figure 1Unusually thick lips and mandibular overgrowth.

Investigation {#S0004}
=============

Growth Hormone levels were high at \>40 ng/mL at the initial visit. OGTT suppression test was done and the fasting GH levels were \>40 ng/mL, 38.6 ng/mL at 1 hrs and 38.7 ng/mL at 2 hrs after the administration of 100 g of glucose.

IGF1 levels were elevated at 783 ng/mL (normal value: 94--252 ng/mL)

Prolactin was 3.98 ng/mL and LH was 12.3 mIU/mL. ACTH (45 pg/mL) and cortisol (9.94 mcg/dl) levels were also within the normal ranges. HbA1c level was 12%. Fasting blood glucose level was 248 mg/dl and postprandial blood glucose level was 322 mg/dl.

MRI of pituitary revealed asymmetrical enlargement of the anterior pituitary gland on the left side with the involvement of the left cavernous sinus (see [Figures 2](#F0002){ref-type="fig"} and [3](#F0003){ref-type="fig"}).Figure 2MRI of the pituitary and the brain. Film number one.Figure 3MRI of the pituitary and the brain. Film number two.

Treatment and Outcome {#S0005}
=====================

Pituitary surgery was performed in November 2017 by Endoscopic Endonasal approach with excision of the pituitary macroadenoma. Three months post-surgery, the GH levels reduced from \>40 ng/mL to 21.8 ng/mL. MRI pituitary, which was repeated 3 months post-surgery, showed a residual mass towards left side of the sella abutting the left ICA and showing homogenous enlargement. Second pituitary surgery was performed 4 months after the first surgery. After the second surgery on the pituitary, cabergoline was initiated at 0.5 mg once weekly to aid in reducing the GH levels which was later decreased to 0.5 mg once weekly and was completely stopped after 1 year. Dopamine agonists like cabergoline are effective and well tolerated treatment in acromegaly in lowering the serum GH levels.[@CIT0012]

During the time of surgery, the blood glucose levels have been controlled with insulin therapy and metformin. Blood glucose levels were maintained below 180 mg/dl. Serum growth hormone levels were tested every 3 months for 2 years.

Three months after the second surgery, the serum GH level further lowered to around 14 ng/mL. Blood glucose levels were controlled with insulin therapy thrice daily which was reduced to twice daily later on along with metformin 1 g twice daily. At much later stage the blood glucose levels were controlled with metformin, sitagliptin and insulin once daily instead of twice daily. The HbA1c levels reduced from 12% at the initial diagnosis of acromegaly to 6.4% ([Table 1](#T0001){ref-type="table"}) two years post surgery. It took almost 2 years since the first surgery on the pituitary for the serum GH levels to reduce to 7 ng/mL ([Table 2](#T0002){ref-type="table"}). At this stage, all the medications directed towards the control of blood glucose levels including insulin and oral medications were stopped due to repeated incidents of hypoglycemia. Even after stopping all the medications for diabetes mellitus, the blood glucose levels have been well controlled with fasting blood glucose at around 130 mg/dl and postprandial blood glucose around 160 mg/dl and HbA1C of around 6.4%. Table 1Growth Hormone Levels TimelineGH levels at the initial visit and diagnosis\>40 ng/mLGH levels 3 months after the 1^st^ surgery21.8 ng/mLGH levels 3 months after the 2^nd^ surgery14 mg/mLGH levels 2 years after the first visit to the hospital07 ng/mL Table 2HbA1c Levels TimelineHbA1c levels at the initial visit12%HbA1c 3 months after the 1s^t^ surgery with insulin replacement and metformin8%HbA1c 3 months after the 2nd surgery with insulin replacement and metformin7.4%HbA1c 2 years after the 1st visit and 3 months after stopping all the medications directed towards diabetes mellitus6.4%

Discussion {#S0006}
==========

Acromegaly is rare and occurs in around 2.8 to 13.7 per 100,0000 people.[@CIT0006] Diabetes mellitus is present in around 12--37% of patients with acromegaly.[@CIT0007] High serum growth hormone levels lead to high blood glucose state because of high insulin resistance, gluconeogenesis and also lipolysis. Patients with acromegaly can also develop ketoacidosis. In fact in some patients with acromegaly, diabetic ketoacidosis can be the presenting complaint before the diagnosis of acromegaly is made.[@CIT0010] Hormones like glucagon, adrenaline, cortisol and growth hormone antagonize the insulin effect on blood glucose levels and thereby increasing the blood glucose levels.[@CIT0008],[@CIT0009] Also, growth hormone increases the blood glucose levels through gluconeogenesis.[@CIT0011] As the patients GH levels kept increasing over the years, blood glucose levels in this patient also kept fluctuating with high HbA1c levels for 5 years before the acromegaly was diagnosed. Once the GH levels reduced to around 7 ng/mL, the medications directed towards diabetes mellitus had to be completely stopped, This indicates in some cases of acromegaly where there is very high production of GH, even long-standing diabetes mellitus might resolve in some cases after drastic reduction in the GH levels. It took more than 2 years for the medications directed towards diabetes mellitus to be stopped in this patient.

Also, some signs and symptoms which were present at the time of diagnosis of acromegaly like sleep apnea, hypertension, recurrent headaches and soft tissue swelling have subsided. However, skull deformities like cranial thickening did not show much improvement which is usually seen in many patients of acromegaly even if their GH levels have drastically reduced.[@CIT0014]

Though most cases of Acromegaly are benign and non-aggressive, some can behave aggressively compromising local surrounding structures. These tumors tend to recur after the pituitary surgery and respond poorly to the somatostatin analogs.[@CIT0013] Treatment with somatostatin analogs bound with ^90^Y-DOTATATE maybe an option for aggressive tumors not responding to other methods.[@CIT0015]
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